Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia

Citation metadata

From: The New England Journal of Medicine(Vol. 363, Issue 26)
Publisher: Massachusetts Medical Society
Document Type: Clinical report
Length: 40 words

Document controls

Main content

Abstract :

A study was conducted to evaluate the efficacy of Imatinib plus peginterferon alfa-2a in the treatment of chronic myeloid leukemia (CML). Results indicated that such a form of treatment resulted in significantly higher rates of molecular response in such patients.

Source Citation

Source Citation   

Gale Document Number: GALE|A247663156